Skip to Content

BMS 300 mg 3622 (Reyataz 300 mg)

Generic Name: atazanavir

Pill imprint BMS 300 mg 3622 has been identified as Reyataz 300 mg.

Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Reyataz 300 mg BMS 300 mg 3622
Reyataz 300 mg BMS 300 mg 3622
Reyataz 300 mg BMS 300 mg 3622
Reyataz
Generic Name:
atazanavir
Imprint:
BMS 300 mg 3622
Strength:
300 mg
Color:
Red / Blue
Size:
23.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-3622
Inactive Ingredients:
crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5864 A-S Medication Solutions, LLC (repackager)
54868-5838 Physicians Total Care Inc (repackager)
35356-0114 Lake Erie Medical and Surgical Supply (repackager)
68258-1985 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide